ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
Dyslipidaemias in elderly patients [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(5): 25-28 | DOI: 10.5543/tkda.2017.39483

Dyslipidaemias in elderly patients

Aytül Belgi Yıldırım, Ali Yaşar Kılınç
Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey

Statin use in people over 65 years of age is high. A meta-analysis of older patients included in randomised trials found good evidence that statins reduce vascular events and mortality in people with existing coronary heart disease. In older adults, exposure to higher doses of statins or higher potency statins does not increase their effectiveness, but does increase the risk of adverse effects such as myopathy and cognitive impairment. Increasing age is a risk factor for adverse events with statins. Older patients may be less resilient to these effects. Older patients may have more comorbidities and be taking more concomitant drugs than the study populations in statin trials. Applying the evidence for statins to older individuals therefore requires frequent review and consideration of the therapeutic goals and potential benefits and harms.

Keywords: Dyslipidemias, elderly patients.

How to cite this article
Aytül Belgi Yıldırım, Ali Yaşar Kılınç. Dyslipidaemias in elderly patients. Turk Kardiyol Dern Ars. 2017; 45(5): 25-28

Corresponding Author: Aytül Belgi Yıldırım, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.